NanJing Pharmaceutical's return on equity level is worrisome...
NanJing Pharmaceutical's return on equity level is worrisome given its significantly utilized debt. Usually, a high ROE firm without debt is seen as superior. Between two firms with analogous debt-to-equity, the preference is for the higher ROE.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000152e930b755727.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment